Home Liver Diseases Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice

Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice

Credits to the Source Link Daniel
Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice
  • 1.

    Trauner M, Fickert P, Stauber RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol. 1999;14:946–59.

    CAS 
    PubMed 

    Google Scholar
     

  • 2.

    Reichert MC, Lammert F. ABCB4 gene aberrations in human liver disease: an evolving spectrum. Semin Liver Dis. 2018;38:299–307.

    CAS 
    PubMed 

    Google Scholar
     

  • 3.

    Moustafa T, Fickert P, Magnes C, Guelly C, Thueringer A, Frank S, et al. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. Gastroenterology. 2012;142:140–51.

    CAS 
    PubMed 

    Google Scholar
     

  • 4.

    Ikenaga N, Liu SB, Sverdlov DY, Yoshida S, Nasser I, Ke Q, et al. A new Mdr2(−/−) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer. Am J Pathol. 2015;185:325–34.

    CAS 
    PubMed 

    Google Scholar
     

  • 5.

    Mendes LC, Stucchi RS, Vigani AG. Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies. Hepat Med. 2018;10:13–22.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 6.

    Choi HSJ, Brouwer WP, Zanjir WMR, Man RA, de, Feld JJ, Hansen BE, et al. Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology. 2020;71:539–48.

    CAS 
    PubMed 

    Google Scholar
     

  • 7.

    Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA. 1987;84:6909–13.

    CAS 
    PubMed 

    Google Scholar
     

  • 8.

    Chung Y-L, Wu M-L. The role of promyelocytic leukemia protein in steatosis-associated hepatic tumors related to chronic hepatitis B virus infection. Transl Oncol. 2018;11:743–54.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 9.

    Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989;59:1145–56.

    CAS 
    PubMed 

    Google Scholar
     

  • 10.

    Churin Y, Roderfeld M, Stiefel J, Würger T, Schröder D, Matono T, et al. Pathological impact of hepatitis B virus surface proteins on the liver is associated with the host genetic background. PLoS ONE. 2014;9:e90608.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 11.

    Montalbano R, Honrath B, Wissniowski TT, Elxnat M, Roth S, Ocker M, et al. Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells. Oncotarget. 2016;7:20312–23.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 12.

    Bondini S, Kallman J, Wheeler A, Prakash S, Gramlich T, Jondle DM, et al. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007;27:607–11.

    PubMed 

    Google Scholar
     

  • 13.

    Liang J, Liu F, Wang F, Han T, Jing L, Ma Z, et al. A noninvasive score model for prediction of NASH in patients with chronic hepatitis B and nonalcoholic fatty liver disease. Biomed Res Int. 2017;2017:8793278.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 14.

    Roeb E, Geier A. Nonalcoholic steatohepatitis (NASH)—current treatment recommendations and future developments. Z Gastroenterol. 2019;57:508–17.

    PubMed 

    Google Scholar
     

  • 15.

    Alwahsh SM, Gebhardt R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Arch Toxicol. 2017;91:1545–63.

    CAS 
    PubMed 

    Google Scholar
     

  • 16.

    Brandt A, Hernández-Arriaga A, Kehm R, Sánchez V, Jin CJ, Nier A, et al. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. Sci Rep. 2019;9:6668.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 17.

    Mahli A, Saugspier M, Koch A, Sommer J, Dietrich P, Lee S, et al. ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis. Gut. 2018;67:746–56.

    CAS 
    PubMed 

    Google Scholar
     

  • 18.

    Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007;100:328–41.

    CAS 
    PubMed 

    Google Scholar
     

  • 19.

    Wang Q, Liu S, Zhai A, Zhang B, Tian G. AMPK-mediated regulation of lipid metabolism by phosphorylation. Biol Pharm Bull. 2018;41:985–93.

    CAS 
    PubMed 

    Google Scholar
     

  • 20.

    Herzig S, Hedrick S, Morantte I, Koo S-H, Galimi F, Montminy M. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature. 2003;426:190–3.

    CAS 
    PubMed 

    Google Scholar
     

  • 21.

    Kimmel AR, Brasaemle DL, McAndrews-Hill M, Sztalryd C, Londos C. Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. J Lipid Res. 2010;51:468–71.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 22.

    Kaushik S, Cuervo AM. AMPK-dependent phosphorylation of lipid droplet protein PLIN2 triggers its degradation by CMA. Autophagy. 2016;12:432–8.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 23.

    Zahner D, Glimm H, Matono T, Churin Y, Herebian D, Mayatepek E, et al. Hepatitis B virus surface proteins accelerate cholestatic injury and tumor progression in Abcb4-knockout mice. Oncotarget. 2017;8:52560–70.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 24.

    Roderfeld M, Rath T, Lammert F, Dierkes C, Graf J, Roeb E. Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC. World J Hepatol. 2010;2:175–9.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 25.

    Roderfeld M, Rath T, Voswinckel R, Dierkes C, Dietrich H, Zahner D, et al. Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice. Hepatology. 2010;51:267–76.

    CAS 
    PubMed 

    Google Scholar
     

  • 26.

    Roderfeld M, Padem S, Lichtenberger J, Quack T, Weiskirchen R, Longerich T, et al. Schistosoma mansoni egg-secreted antigens activate hepatocellular carcinoma-associated transcription factors c-Jun and STAT3 in hamster and human hepatocytes. Hepatology. 2018. https://doi.org/10.1002/hep.30192.

  • 27.

    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402–8.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 28.

    Anderson AA, Altafaj X, Zheng Z, Wang Z-M, Delbono O, Ronjat M, et al. The junctional SR protein JP-45 affects the functional expression of the voltage-dependent Ca2+ channel Cav1.1. J Cell Sci. 2006;119:2145–55.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 29.

    Laggai S, Simon Y, Ranssweiler T, Kiemer AK, Kessler SM. Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH. World J Hepatol. 2013;5:558–67.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 30.

    Krüger S, Bürmann L, Morlock GE. Comparison and characterization of soybean and sunflower lecithins used for chocolate production by high-performance thin-layer chromatography with fluorescence detection and electrospray mass spectrometry. J Agric Food Chem. 2015;63:2893–901.

    PubMed 

    Google Scholar
     

  • 31.

    Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol. 1992;66:4107–16.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 32.

    Tsai T-H, Chen E, Li L, Saha P, Lee H-J, Huang L-S, et al. The constitutive lipid droplet protein PLIN2 regulates autophagy in liver. Autophagy. 2017;13:1130–44.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 33.

    Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr. 2001;21:193–230.

    CAS 
    PubMed 

    Google Scholar
     

  • 34.

    Deng T, Shan S, Li P-P, Shen Z-F, Lu X-P, Cheng J, et al. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1. Endocrinology. 2006;147:875–84.

    CAS 
    PubMed 

    Google Scholar
     

  • 35.

    Heidrich F, Schotola H, Popov AF, Sohns C, Schuenemann J, Friedrich M, et al. AMPK-activated protein kinase and its role in energy metabolism of the heart. Curr Cardiol Rev. 2010;6:337–42.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 36.

    Thomson DM, Herway ST, Fillmore N, Kim H, Brown JD, Barrow JR, et al. AMP-activated protein kinase phosphorylates transcription factors of the CREB family. J Appl Physiol. 2008;104:429–38.

    CAS 
    PubMed 

    Google Scholar
     

  • 37.

    Shipovskaya AA, Dudanova OP. Intrahepatic cholestasis in nonalcoholic fatty liver disease. Ter Arkh. 2018;90:69–74.

    CAS 
    PubMed 

    Google Scholar
     

  • 38.

    Rigopoulou EI, Zachou K, Gatselis NK, Papadamou G, Koukoulis GK, Dalekos GN. Primary biliary cirrhosis in HBV and HCV patients: clinical characteristics and outcome. World J Hepatol. 2013;5:577–83.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 39.

    Javaid A, Poongkunran M, Allard FD, Kyaw W, Maung HH, Lau D. Subtle presentation of active primary biliary cirrhosis in chronic hepatitis B: a case report. Gastroenterol Rep. 2017;5:157–60.


    Google Scholar
     

  • 40.

    Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2008;27:80–9.

    CAS 
    PubMed 

    Google Scholar
     

  • 41.

    Aguiar Vallim TQ, de, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17:657–69.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 42.

    Montagner A, Polizzi A, Fouché E, Ducheix S, Lippi Y, Lasserre F, et al. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut. 2016;65:1202–14.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 43.

    Rakhshandehroo M, Sanderson LM, Matilainen M, Stienstra R, Carlberg C, Groot PJde, et al. Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. PPAR Res. 2007;2007:26839.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 44.

    Liu G, Xu J-N, Liu D, Ding Q, Liu M-N, Chen R, et al. Regulation of plasma lipid homeostasis by hepatic lipoprotein lipase in adult mice. J Lipid Res. 2016;57:1155–61.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 45.

    Takeuchi K, Reue K. Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. Am J Physiol Endocrinol Metab. 2009;296:1195–209.


    Google Scholar
     

  • 46.

    Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45:1366–74.

    CAS 
    PubMed 

    Google Scholar
     

  • 47.

    Hardie DG. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol. 2007;47:185–210.

    CAS 
    PubMed 

    Google Scholar
     

  • 48.

    Cai S-Y, Mennone A, Soroka CJ, Boyer JL. Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2014;306:670–6.


    Google Scholar
     

  • 49.

    Imai Y, Boyle S, Varela GM, Caron E, Yin X, Dhir R, et al. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression. Physiol Genomics. 2012;44:1125–31.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 50.

    Garcia D, Shaw RJ. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell. 2017;66:789–800.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Source Link

    Related Articles

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

    %d bloggers like this: